GlobalIPNews

Sign Up
|
Login
|

23:03:07 Tue 17 Mar 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Shanghai Jiao Tong Univer

(46)

Tianjin University

(44)

Tianjin University of Sci

(10)

Eli Lilly and Company

(8)

China Pharmaceutical Univ

(6)

Jiangsu Kanion Pharmaceut

(6)

Meilan Hangzhou Pharmaceu

(6)

Shenyang Pharmaceutical U

(6)

Tianjin University of Tec

(6)

Guangdong Pharmaceutical

(5)

Ruijin Hospital Shanghai

(5)

Sanofi-Aventis Deutschlan

(5)

Shandong New Time Pharmac

(5)

Shenzhen Salubris Pharmac

(5)

Xiangya Hospital Central

(5)

Corcept Therapeutics

(4)

Henan University of Chine

(4)

Institute of Materia Medi

(4)

Nanjing University of Chi

(4)

(4)

(4)

Shanghai Jiao Tong Univer

(4)

Sichuan University

(4)

Sirio Pharma Co Ltd; Xiam

(4)

Aiqiji Creation

(3)

Algen Pharmaceuticals Inc

(3)

(3)

Bs Biotechna Spolka Akcyj

(3)

Central South University

(3)

Chengdu University of Tra

(3)

China Pharmaceutical Univ

(3)

F Hoffmann La Roche Ag [c

(3)

Foshan Power Supply Burea

(3)

Guangzhou Baiyun Shan Min

(3)

Hoffmann-La Roche

(3)

Hubei Shuangxing Pharmace

(3)

Inst Med Biotechnology Ca

(3)

Institute Military Medici

(3)

Jiangsu Nhwa Pharmaceutic

(3)

Kalititas Therapeutics In

(3)

Nanjing Heron Pharmaceuti

(3)

Nantong University

(3)

Renji Hospital Shanghai J

(3)

Shandong Nuomingkang Phar

(3)

Shanghai University of Tr

(3)

Shenzhen Haoshi Biologica

(3)

Sichuan Credit Pharmaceut

(3)

Sichuan Huili Ind Co Ltd

(3)

Softwave Tissue Regenerat

(3)

Soochow University

(3)

Suzhou Dawnrays Pharmaceu

(3)

The Fourth Engineering of

(3)

Tianjin University of Tra

(3)

Tongji Medical College Ho

(3)

Voyager Therapeutics

(3)

Xinhua Hospital affiliate

(3)

Yangtze River Delta Smart

(3)

Zhejiang Chinese Medical

(3)

Zhongjing Wanxi Pharmaceu

(3)

Affiliated Hospital of Ji

(2)

Affiliated Hospital of Sh

(2)

Aldena Therapeutics [gb];

(2)

Alicorn Pharmaceutical Co

(2)

Alnylam Pharmaceuticals

(2)

(2)

Anhui Changjiang Pharmace

(2)

Arizona Board of Regents

(2)

Ascendis Pharma

(2)

Aurisco Pharmaceutical Ti

(2)

Baoding Jizhong Pharmaceu

(2)

Baowu Special Metallurgy;

(2)

Beijing Fuyuan Pharmaceut

(2)

Beijing Orbiepharm Co Ltd

(2)

Beijing Shumande Pharmace

(2)

Beijing University

(2)

Bioprojet Soc Civ

(2)

Blueprint Medicines

(2)

Boehringer Ingelheim Inte

(2)

(2)

Celgene Corp (celgene Co

(2)

Celyntra Therapeutics

(2)

Centrum Badan Molekularny

(2)

Changchun GeneScience Pha

(2)

Changchun University of C

(2)

Changchunteng Biological

(2)

Changde No 1 Traditional

(2)

Chia Tai Tianqing Pharmac

(2)

China Academy of Chinese

(2)

Chongqing Hospital Of Tra

(2)

Cloneopt Ab [se]; Xbrane

(2)

Duke University

(2)

East China University of

(2)

Egle Therapeutics

(2)

Eisai R&D Management

(2)

Emory University

(2)

First Affiliated Hospital

(2)

First Teaching Hospital,

(2)

Fujian Kaixin Pharmaceuti

(2)

Fuzhou Jishi Pharmaceutic

(2)

GH Research, Ireland

(2)

Gan & Lee Pharmaceuticals

(2)

Genentech Inc [us]; Hoffm

(2)

(2)

Guangdong Second Traditio

(2)

Guangji Pharmaceutical Ji

(2)

Guangshengtang Zhongxing

(2)

Guangzhou Bebetter Medici

(2)

Hangzhou Yisikang Pharmac

(2)

Hebei Yiling Medicine Res

(2)

Hefei University of Techn

(2)

Heilongjiang University o

(2)

Henan University of Techn

(2)

Hoffmann La Roche

(2)

Hoffmann La Roche [ch]; R

(2)

Hubei Shengtong Rongzhi T

(2)

Hunan Academy of Chinese

(2)

Hunan Aiweigelin Pharmace

(2)

Hunan University of Chine

(2)

Infinity Biopharma Inc

(2)

Inst Of Military Veterina

(2)

Institute of Chinese Mate

(2)

Jiangsu Demai Pharmaceuti

(2)

Jiangsu Institute of Poul

(2)

Jiangsu Jiming Pharmaceut

(2)

Jiangsu Province Hospital

(2)

Jiangsu Skyrun Pharmaceut

(2)

Jiangxi University of Tra

(2)

Jilin Acad Of Chinese Med

(2)

Jinpai Chizhengtang Pharm

(2)

Jinzhou Ahon Pharmaceutic

(2)

Korea Institute of Radiol

(2)

Kpc Pharmaceuticals Inc;

(2)

Kunming University of Sci

(2)

Lanzhou Foci Pharmaceutic

(2)

Nanjing Sanhome Pharmaceu

(2)

Nanjing Santong Pharmaceu

(2)

(2)

Otsuka Pharmaceutical

(2)

PLA Air Force Medical Uni

(2)

Qilu Pharmaceutical

(2)

Qingdao Central Hospital

(2)

Qingdao Huashang Xinyao P

(2)

Regeneron Pharmaceuticals

(2)

Ringpu Tianjin Bio Pharm

(2)

Rna Therapeutics Inc

(2)

SZYY Group Pharmaceutical

(2)

(2)

Sensionextrusion Therapeu

(2)

Shaanxi University of Sci

(2)

Shandong University of Tr

(2)

Shanghai Hansoh Biomedica

(2)

Shanghai Inst Of Pharmace

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Putuo Distr Cent

(2)

Shanghai Wonder Pharmaceu

(2)

Shijiazhuang Zangnuo Phar

(2)

Sichuan College Tradition

(2)

Sigilon Therapeutics

(2)

State Grid Shanghai Munic

(2)

Sun Yat-sen University

(2)

Suzhou Teyijie Biological

(2)

Suzhou Wangshan Wangshui

(2)

Teven Therapeutics Pty Lt

(2)

The Regents of The Univer

(2)

Tianjin University; Hisen

(2)

Tianjin University; Xiame

(2)

Tongyitang Pharm Co Ltd

(2)

Union Therapeutics As

(2)

Univ Jagiellonski

(2)

Univ Medyczny W Bialymsto

(2)

University Yunnan Traditi

(2)

University of Washington

(2)

Wanbangde Pharmaceutical

(2)

Wenxian Huaifang Bencao P

(2)

West China Hospital, Sich

(2)

Wuhan Polytechnic Univers

(2)

Wyvern Pharmaceuticals

(2)

Xiamen Changkexin Antibod

(2)

Xinjiang Huachun Biologic

(2)

(2)

Yichang Humanwell Pharmac

(2)

Yunnan Chengjiang Lotus R

(2)

Yunnan Minzu University

(2)

Zhejiang Cancer Hospital

(2)

Zhejiang University

(2)

Zunyi Campus Of Zunyi Med

(2)

(1)

3i Biotech Llc [us]; Texa

(1)

(1)

4e Therapeutics Inc

(1)

4moving Biotech [fr]; Sor

(1)

60 Degrees Pharmaceutical

(1)

Aconcagua Bio Inc

(1)

Acousia Therapeutics Gmbh

(1)

(1)

Adneurotherapeutics Inc

(1)

Advisory Spolka Z Ogranic

(1)

Affiliated Hospital of Ji

(1)

Affiliated Hospital of Sh

(1)

Affiliated Hospital of So

(1)

Affiliated Tumor Hospital

(1)

Agensys Inc; Sijin Co Ltd

(1)

Agrichina Pharmaceutical

(1)

Agwi [fr]; Ecole Nat Supe

(1)

Ajax Therapeutics

(1)

Akagra Pharmaceuticals In

(1)

Akebia Therapeutics Inc

(1)

Albert Einstein College M

(1)

Albius Sciences Beta Pte

(1)

(1)

Alexion Pharmaceuticals

(1)

Alkermes Pharma Ireland L

(1)

(1)

Alpha Pharmaceutical Co L

(1)

Altamira Therapeutics Inc

(1)

(1)

Anhui Haikang Pharmaceuti

(1)

Anhui Huakang Pharmaceuti

(1)

Anhui Jilekang Pharmaceut

(1)

Anhui Kangzheng Kangyuan

(1)

Anhui Medical University

(1)

Anhui Medical University;

(1)

Anhui Protek Biotechnolog

(1)

Anhui Senquangu Medicine

(1)

Anhui University of Techn

(1)

Anhui Yuanjing Pharmaceut

(1)

Anhui Yuebo Biopharmaceut

(1)

Anhui Zhifei Longcom Biop

(1)

Anji Pharma Us Llc (anji

(1)

Anovis Biologics Inc

(1)

Antecip Bioventures

(1)

Apellis Pharmaceuticals

(1)

Apet Holding B V

(1)

Apogee Therapeutics Inc

(1)

(1)

Apothecary Products Llc

(1)

Aquitive Therapeutics Inc

(1)

Aratana Therapeutics Inc

(1)

Arcus Biosciences

(1)

Aribio Co Ltd [kr]; Bioch

(1)

Arite Pharmaceutical Co L

(1)

Arromax Pharmatech Co Ltd

(1)

Arvinas Operation Inc

(1)

Ascendis Pharma Ophthalmo

(1)

Asieris Pharmaceuticals S

(1)

(1)

Atai Therapeutics

(1)

Atom High Technology

(1)

(1)

Attiba Joshua O

(1)

Augusta Univ Research Ins

(1)

Baiyu Tibetan Hospital

(1)

Baoding Xuzhuo Bio Tech C

(1)

Baotou Medical College

(1)

Basecure Therapeutics Llc

(1)

Bausch Lomb Ireland

(1)

Bausch+Stroebel

(1)

Baxalta Inc; Baxalta Gmbh

(1)

(1)

Bayer Pharmaceutical

(1)

Beijing Ceyi Biotechnolog

(1)

Beijing Chest Hospital Ca

(1)

Beijing Daderuyang Intern

(1)

Beijing Donghuayuan Medic

(1)

Beijing Hongyi Jishi Phar

(1)

Beijing Huawei Tianhe Bio

(1)

Beijing Inno Medicine Co

(1)

Beijing Innocare Pharma T

(1)

Beijing Jianhua Medical R

(1)

Beijing Jiatuo Pharmaceut

(1)

Beijing Jingfeng Pharmace

(1)

Beijing Jiuxi Kanghua Pha

(1)

Beijing Joinn Pharmaceuti

(1)

Beijing Kanghai Pharmaceu

(1)

Beijing Nabai Biotechnolo

(1)

Beijing Neurosurgical Ins

(1)

Beijing Normal University

(1)

Beijing Peking Univ Wbl B

(1)

Beijing Ruiye Pharmaceuti

(1)

Beijing Silian Pharmaceut

(1)

Beijing Tianzhen Tech Co

(1)

Beijing Union Pharmaceuti

(1)

Beijing Yifangding Tech C

(1)

Beijing Yousun Pharmaceut

(1)

Beijing Zhiyu Biotechnolo

(1)

Beijing Zitiao Network Te

(1)

Beijing Zoo Man Office

(1)

Beimei Res & Development

(1)

Biaoxin Biomedical Tech S

(1)

Big Data Center State Gri

(1)

Binuoji Shanghai Biotechn

(1)

Bio Merieux Inc

(1)

Biocells Beijing Biotechn

(1)

Biohifin Therapeutics Ltd

(1)

BlossomHill Therapeutics

(1)

Blue Marlin Therapeutics

(1)

Board of Regents of the U

(1)

Boehringer Ingelheim Rcv

(1)

Bohui Biopharmaceutical C

(1)

Bolt Biotherapeutics

(1)

Bozhou People\'s Hospital

(1)

Bozhou University

(1)

(1)

CCC Guangzhou Dredging; S

(1)

CETC Zhiwei Shanghai Tech

(1)

CETC Zhiwei Shanghai Tech

(1)

(1)

Cancer Research Technolog

(1)

Cangzhou Medical College

(1)

(1)

Capital Medical Universit

(1)

Capital University of Med

(1)

Carboexpert Inc

(1)

Cas Suzhou Intelligent Co

(1)

Cebn Ireland Ltd

(1)

Cell Ecological Haihe Lab

(1)

Centre National de la Rec

(1)

Centro De Inmunologia Mol

(1)

Cerbios Pharma Sa

(1)

Cf Pharmatech Inc

(1)

Chang Matthew Wook [sg];

(1)

Changchun Haiyue Pharmace

(1)

Changchun Lanjiang Pharma

(1)

Changchun Shunshi Tech Co

(1)

Changchun Univ Of Traditi

(1)

Changzhou Kangtai Biologi

(1)

Changzhou Yinsheng Pharma

(1)

(1)

Chengdu Brilliant Pharmac

(1)

Chengdu Gaoxin Southwest

(1)

Chengdu Kanghong Pharmace

(1)

Chengdu Mafeisan Medical

(1)

Chengdu Mfs Pharma Co Ltd

(1)

Chengdu Nuohe Shengtai Bi

(1)

Chengdu Shounuo Pharmaceu

(1)

Chengdu Sibeibo Pharmaceu

(1)

Chengdu Starray Therapeut

(1)

Chengdu University of Tra

(1)

Chengdu Xinrui Zhiyuan Bi

(1)

Chengdu Yazhong Bio Pharm

(1)

China Electric Power Rese

(1)

China Electric Power Rese

(1)

China Inst Veterinary Dru

(1)

China Pharmaceutical Univ

(1)

China Three Gorges Univer

(1)

Chizhou Dongsheng Pharmac

(1)

Chong Kun Dang Pharmaceut

(1)

Chongqing Beishangguang T

(1)

Chongqing Guochengtang Ph

(1)

Chongqing Hongsheng Pharm

(1)

Chongqing Jingbei Tech Co

(1)

Chongqing Kang Ju Quan Ho

(1)

Chongqing University

(1)

Chongqing Wanyuanjia Phar

(1)

Chongqing Yaogu Pharmaceu

(1)

Chung Ang University Indu

(1)

Click Therapeutics

(1)

Cognito Therapeutics

(1)

Colgate-Palmolive

(1)

Cornell Univ [us]; Sander

(1)

Cpi Xinjiang Energy & Che

(1)

Cr Sanjiu Nanchang Pharma

(1)

Cr Sanjiu Yaan Pharmaceut

(1)

Curevac Netherlands B V

(1)

Curevac Se [de]; Sanofi P

(1)

Cyagen Bioinformatics Suz

(1)

(1)

Cyclacel Ltd [gb]; Cyclac

(1)

Cyrano Therapeutics

(1)

DSM IP Assets B V

(1)

Daewoong Pharmaceutical

(1)

Dalian Institute of Chemi

(1)

Dalian Medical University

(1)

Dalian Ocean University

(1)

Dalian Polytechnic Univer

(1)

Dana-Farber Cancer Instit

(1)

Dark Canyon Laboratories

(1)

Dassama Therapeutics Inc

(1)

Dermatology Hospital of S

(1)

Dermavant Sciences Gmbh

(1)

Descartes Therapeutics In

(1)

Dezhou Redsun Pharmaceuti

(1)

Diao Group Chengdu Pharma

(1)

Domain Therapeutics S A

(1)

(1)

Dongfang Hospital Beijing

(1)

Dongguan Hongyuan Pharmac

(1)

(1)

Ducentis Biotherapeutics

(1)

Duchesnay Inc (duchesnay

(1)

(1)

ETA SA Manufacture Horlog

(1)

East China University of

(1)

Effector Therapeutics Inc

(1)

Elabscience Wuhan Biotech

(1)

Elanco Us Inc (elanco Us

(1)

(1)

Electric Power Research I

(1)

Emeishan Tonghui Pharmace

(1)

Enanta Pharmaceuticals

(1)

Ennovate Pharma [fr]; Red

(1)

Eraysco Pharmaceutical Re

(1)

(1)

F Hoffmann La Roche Ag [c

(1)

(1)

(1)

Feiman Changchun Pharmace

(1)

(1)

Findair Spolka Z Ogranicz

(1)

Firebrick Pharma Pty Ltd

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

First Hospital China Medi

(1)

First Hospital of Jilin U

(1)

Fitoplancton Marino S L

(1)

Foresight Biotherapeutics

(1)

Foshan Inst Of Biomedical

(1)

Frare Therapeutics Inc

(1)

Fudan University

(1)

Fudan University Shanghai

(1)

Fujian Cosunter Pharmaceu

(1)

Fujian Huian Huiteng Glas

(1)

Fujian Jinuo Houpu Biotec

(1)

Fujian University of Trad

(1)

Fushun Tianrun Biotechnol

(1)

Fuxing Antejin Chengdu Bi

(1)

Fuzhou Neptunus Jinxiang

(1)

Fuzhou Xinbo Yanqiao Phar

(1)

Ganacyte Therapeutics Inc

(1)

Ganli Pharmaceutical Shan

(1)

Gansu Fanzhi Pharmaceutic

(1)

Gansu Medical College

(1)

Gansu Provincial Hospital

(1)

Ganzhou Comprehensive Ins

(1)

(1)

Genentech Inc [us]; F Hof

(1)

Genentech Inc [us]; Roche

(1)

Genesis Molecular Ai Inc

(1)

Gilead Sciences Inc (gil

(1)

Gilgames Pharma Inc

(1)

(1)

Gkh Pharmaceutical Ltd

(1)

Glaxo Group Ltd

(1)

GlaxoSmithKline Intellect

(1)

Glaxosmithkline Intellect

(1)

Glenmark Pharmaceuticals

(1)

Global Biolife Inc

(1)

Grand Pharma China Co Ltd

(1)

Green Trend Co Ltd

(1)

Gu Sanyuan; Xu Jingyu

(1)

Guangdong Danxia Bio Phar

(1)

Guangdong Enterlife Pharm

(1)

Guangdong Gaodeng Pharmac

(1)

Guangdong HEC Pharmaceuti

(1)

Guangdong Hongshanhu Phar

(1)

Guangdong Huajian Biologi

(1)

Guangdong Jiachuang Pharm

(1)

Guangdong Lewwin Pharmace

(1)

Guangdong Lustre Pharmace

(1)

Guangdong Pharmaceutical

(1)

Guangdong Qingyunshan Pha

(1)

Guangdong Xingbang Pharma

(1)

Guangdong Yangble Biophar

(1)

Guangdong Yifang Pharmace

(1)

Guangdong Zhongte Health

(1)

Guangdong Zhuotai Pharmac

(1)

Guangxi Baoruitan Pharmac

(1)

Guangxi Hospital Affiliat

(1)

Guangxi Medical College

(1)

Guangxi University for Na

(1)

Guangxi University of Chi

(1)

Guangxi Xianshouqi Pharma

(1)

Guangxi Yulin Pharmaceuti

(1)

Guangxi Zhongtai Health B

(1)

Guangxi Zhuang Autonomous

(1)

Guangzhou Baiji Shenzhou

(1)

Guangzhou Bona Pharmaceut

(1)

Guangzhou Daguang Pharmac

(1)

Guangzhou Deaou Medical T

(1)

Guangzhou Fandi Cosmetics

(1)

Guangzhou Green Cross Pha

(1)

Guangzhou Hanfang Pharmac

(1)

Guangzhou Jinan Biomedica

(1)

Guangzhou Medical Univers

(1)

Guangzhou National Labora

(1)

Guangzhou Shaai Biologica

(1)

Guangzhou Youya Daily Che

(1)

Guangzhou Yuerui Biotechn

(1)

Guangzhou Zhongke Baishi

(1)

Gugeer Pharmaceutical Hai

(1)

Guizhou Fisheries Res Ins

(1)

Guizhou Huangguoshu Lishu

(1)

Guizhou Institute Of Biot

(1)

Guizhou Jingcheng Pharmac

(1)

Guizhou Jinguanzi Pharmac

(1)

Guizhou Jisheng Pharmaceu

(1)

Guizhou Miaote Pharmaceut

(1)

Guizhou Natural Product R

(1)

Guizhou Southeast Miao An

(1)

Guizhou University

(1)

Haichuang Pharmaceutical

(1)

Haier Biomedical Tech Nan

(1)

Haikou Peoples Hospital C

(1)

Haikou Pharmaceutical Fac

(1)

Haikou Qiaoshui United Te

(1)

Hainan Asia Pharmaceutica

(1)

Hainan Hengcheng Sanye Ph

(1)

Hainan Jinrui Pharmaceuti

(1)

Hainan Tianhu Application

(1)

Hainan Wanwei Pharmaceuti

(1)

Hainan Yunze Pharmaceutic

(1)

Halozyme Hypercon Inc

(1)

Halozyme Inc (halozyme I

(1)

Handan Pharmaceutical Co

(1)

Hangzhou Baotai Biotechno

(1)

Hangzhou Bozhirui Biologi

(1)

Hangzhou Hunter Biotechno

(1)

Hangzhou Medical College

(1)

Hangzhou Sanyan Biologica

(1)

Hangzhou Shiliao Jingyuan

(1)

Hangzhou Tianfan Biotechn

(1)

Hangzhou Viablife Biotech

(1)

Hangzhou Xingao Biotechno

(1)

Hangzhou Xinglin Informat

(1)

Hanmi Science Co Ltd

(1)

Hansoh Bio Llc [us]; Shan

(1)

Hantian Biological Beijin

(1)

Harbin Commercial Univers

(1)

Harbin Hanjun Modern Phar

(1)

Harbin Lvdasheng Animal M

(1)

Harbin Medical University

(1)

Harbin Tongyitang Pharmac

(1)

Health Decode Pharmacy Gu

(1)

Healthy Yuanhaibin Pharma

(1)

Hebei Fangmian Medical De

(1)

Hebei Greenland Animal Ph

(1)

Hebei Guolong Pharmaceuti

(1)

Hebei Institute For Drug

(1)

Hebei Jingfengtang Pharma

(1)

Hebei Keyi Hospital Man C

(1)

Hebei Lisheng Pharmaceuti

(1)

Hebei Province Pharmaceut

(1)

Hebei Tongluo Pharmaceuti

(1)

Hefei Industrial Pharmace

(1)

Hefei Kejiusheng Biologic

(1)

Hefei Licheng Pharmaceuti

(1)

Hefei Tiangang Immunology

(1)

Hefei University of Techn

(1)

(1)

Heilongjiang Acad Of Tcm

(1)

Heilongjiang Guokang Jiay

(1)

Heilongjiang Jiren Pharma

(1)

Heji Hospital Affiliated

(1)

Helsinn Healthcare Sa [ch

(1)

Henan Chemical Industry R

(1)

Henan Dongjitang Health T

(1)

Henan Institute of Scienc

(1)

Henan Jinbaihe Biotechnol

(1)

Henan Lvhe Pharmaceutical

(1)

Henan Meisen Pharmaceutic

(1)

Henan Xiangyu Medical Equ

(1)

Hengyang Kexingtianxia Li

(1)

Heping Hospital of Changz

(1)

Hiddink Daniel [ch]; Hmh

(1)

Hirakawa Hewtech Corp

(1)

Hoffmann La Roche [ch]; R

(1)

Hong Kong Polytechnic Uni

(1)

Hong Kong Polytechnic Uni

(1)

Hong Kong University of S

(1)

(1)

Horqin Right Wing Zhongqi

(1)

Hospital Affiliated To Fu

(1)

Hospital of Stomatology,

(1)

Huahong Pharmaceutical Gr

(1)

(1)

(1)

Huangshan Bonsun Pharmace

(1)

Huangshi Shixing Pharmace

(1)

Huaxiashengsheng Pharmace

(1)

Huayi Pharmaceutical Anhu

(1)

Huayi Taikang Pharmaceuti

(1)

Huazhong University of Sc

(1)

Hubei Chengtian Pharmaceu

(1)

Hubei Chuwei Pharmaceutic

(1)

Hubei Gongtong Zaiti Phar

(1)

Hubei Guangren Medicament

(1)

Hubei Keyi Pharma Co Ltd

(1)

Hubei Lingsheng Pharmaceu

(1)

Hubei Litak Biological En

(1)

Hubei Oumeiqi Machinery E

(1)

Hubei Provincial Hospital

(1)

Hubei Renyue Pharmaceutic

(1)

Hubei University of Medic

(1)

Hubei University of Scien

(1)

Hubei Yitai Pharmacy Co L

(1)

Huida Shanghai Biotechnol

(1)

Huishi Heilongjiang Pharm

(1)

Huizhou Jiuhui Pharmaceut

(1)

Hunan Hexin Pharmaceutica

(1)

Hunan Kelun Pharmaceutica

(1)

Hunan Medical Univ Health

(1)

Hunan Norchem Pharmaceuti

(1)

Hunan Paigelan Pharmaceut

(1)

Hunan Sailong Pharmaceuti

(1)

Hunan Tuberculosis Preven

(1)

Hunan Veterinary Drug And

(1)

Hunan Xinjiu Pharmaceutic

(1)

Hunan Xuancheng Tech Co L

(1)

Hunan Yunzishan Health In

(1)

Hunan Yuxin Pharmaceutica

(1)

Huzhou Central Hospital

(1)

Hybio Pharmaceutical Co L

(1)

IGM Biosciences

(1)

Igi Therapeutics Sa

(1)

Imbria Pharmaceuticals

(1)

Immune Targeting Inc

(1)

(1)

Immunotek Co Ltd

(1)

Impact Therapeutics Inc

(1)

Incyte Holdings Corp (in

(1)

Inner Mongolia Berun Engi

(1)

Inner Mongolia Conba Phar

(1)

Inner Mongolia Jingdong P

(1)

Inner Mongolia Tianqi Zho

(1)

Inner Mongolia University

(1)

Innocare Pharma Inc [us];

(1)

Inspection Therapeutics I

(1)

Inst Chemii I Techniki Ja

(1)

Inst Genetyki Roslin Pols

(1)

Institut National De La S

(1)

Institute Of Basic Res In

(1)

Insulet Corporation

(1)

(1)

Invent Spolka Z Ograniczo

(1)

Ionis Pharmaceuticals

(1)

Iox Therapeutics Ltd

(1)

Iucf Hyu Industry Univ Co

(1)

Janssen Biotech

(1)

Janssen Pharmaceutica

(1)

Jazz Pharmaceuticals Rese

(1)

Jecho Biopharma Inc

(1)

Jewim Pharmaceutical Shan

(1)

Jiachen Membrane Xiamen T

(1)

Jiamusi University

(1)

Jiangmen Ligong Qiaobao D

(1)

Jiangnan University; Jian

(1)

Jiangsu Baodong Pharmaceu

(1)

Jiangsu Chifeng Tech Co L

(1)

Jiangsu Coben Pharmaceuti

(1)

Jiangsu Fangsheng Pharmac

(1)

Jiangsu Fubang Pharmaceut

(1)

Jiangsu Hansoh Pharmaceut

(1)

Jiangsu Hansoh Pharmaceut

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Huajing Molecular

(1)

Jiangsu Huanuotai Biologi

(1)

Jiangsu Huiju Pharmaceuti

(1)

Jiangsu Kangbaide Pharmac

(1)

Jiangsu Lilin Medical Tec

(1)

Jiangsu Pengyao Pharmaceu

(1)

Jiangsu Province Hospital

(1)

Jiangsu Simcere Medical D

(1)

Jiangsu Sunan Pharmaceuti

(1)

Jiangsu Targetpharma Labo

(1)

Jiangsu Tiansheng Medical

(1)

Jiangsu Tuohong Kangheng

(1)

Jiangsu University

(1)

Jiangsu University of Sci

(1)

Jiangsu Yike Regenerative

(1)

Jiangsu Yinuoke Biotechno

(1)

Jiangsu Yueshi Pharmaceut

(1)

Jiangsu Yueshi Pharmaceut

(1)

Jiangsu Yunyang Group Pha

(1)

Jiangxi Fangzhu Pharmaceu

(1)

Jiangxi Far East Pharmace

(1)

Jiangxi Juci Tech Co Ltd

(1)

Jiangxi Modern Traditiona

(1)

Jiangxi Pulier Pharmaceut

(1)

Jiangxi Saiou Pharmaceuti

(1)

Jiangxi Synergy Pharmaceu

(1)

Jiangxi University of Tra

(1)

Jiangxi University of Tra

(1)

Jiangxi Yuneng Pharmaceut

(1)

Jianhu County Peoples Hos

(1)

Jilin Acad Of Animal Husb

(1)

Jilin Boda Pharmaceutical

(1)

Jilin Institute Of Scienc

(1)

Jilin Univ Of Chemical Te

(1)

Jilin University

(1)

Jinan Yaxiya Pharmaceutic

(1)

(1)

Jing Jing Pharmaceutical

(1)

Jinling Pharmaceutical Co

(1)

Jinzhong University

(1)

Jinzhong Vocational & Tec

(1)

Julius Maximilians Univ W

(1)

Kaixi Biology Co Ltd

(1)

Kangbaida Sichuan Biomedi

(1)

Kangmei Pharmaceutical

(1)

Kangnuo Biological Pharma

(1)

King Paul Thomas [au]; Bu

(1)

Kiora Pharmaceuticals Pty

(1)

(1)

Kite Therapeutics Inc

(1)

Kobold Sebastian [de]; En

(1)

(1)

Korea Mcnultys Co Ltd

(1)

Kuihua Pharmaceutical Gro

(1)

Kurome Therapeutics Inc

(1)

Kyungpook National Univer

(1)

(1)

(1)

LTZ Therapeutics

(1)

Lanzhou Institute Husband

(1)

Lanzhou University

(1)

Laoshan National Laborato

(1)

Lason Medical Corp

(1)

Lenovo (Beijing) Limited;

(1)

(1)

(1)

(1)

Lianyungang Technical Col

(1)

Liaoning Kangning Pharmac

(1)

(1)

Lintao Sitong Pharmaceuti

(1)

Linxian County Anjiazhuan

(1)

Linyi University

(1)

Linze Xianfeng Machinery

(1)

Lishui City People\'s Hos

(1)

Lishui University; Zhejia

(1)

Liuzhou City Vocational C

(1)

Livzon Pharmaceutical Gro

(1)

Lixin Zhejiang Tech Co Lt

(1)

Lmito Therapeutics Inc

(1)

Longdong University; Lanz

(1)

Longhua Hospital Affiliat

(1)

Longquanyi District Hospi

(1)

Lu Pengcheng; Zunyi Medic

(1)

Luoyang Meilinda Commerce

(1)

Lyotropic Delivery System

(1)

Lysia Therapeutics Inc

(1)

(1)

Madrigal Pharmaceuticals

(1)

Maintain Biomedicine Wuha

(1)

Marengo Therapeutics

(1)

Marvel Biotechnology

(1)

Massachusetts Eye And Ear

(1)

Massachusetts Eye and Ear

(1)

Mayinglong Pharmaceutical

(1)

(1)

Medilabo Rfp Inc [jp]; Un

(1)

Medimmune Ltd (medimmune

(1)

Medshine Discovery Inc [c

(1)

Meihekou Central Blood St

(1)

Meiji Pharmaceutical Univ

(1)

Meixin Jiazhongwei Pharma

(1)

(1)

Merck Sharp & Dohme

(1)

Mervi Us Biotherapeutics

(1)

Mervi Us Biotherapeutics

(1)

(1)

Metafora Biosystems [fr];

(1)

Metala Pharma Inc

(1)

(1)

Mink Therapeutics Inc

(1)

Minxi Vocational & Techni

(1)

Miracle Medicine King Co

(1)

Mitsubishi Tanabe Pharma

(1)

(1)

Morehouse School Of Medic

(1)

Muen Pharmaceutical Equip

(1)

Murdock Tech Llc

(1)

(1)

Nafei (Shenzhen) Pharmace

(1)

Naiji Pharmaceutical Tech

(1)

Nanjing Aimeifei Biologic

(1)

Nanjing Aoluo Biotechnolo

(1)

Nanjing Chia-Tai Tianqing

(1)

Nanjing Congyi Pharmaceut

(1)

Nanjing Drum Tower Hospit

(1)

Nanjing Easeheal Pharmace

(1)

Nanjing Far Shu Pharmaceu

(1)

Nanjing Hanke Mingde Medi

(1)

Nanjing Huabeikang Medica

(1)

Nanjing Huawei Medical Eq

(1)

Nanjing Jimai Biotechnolo

(1)

Nanjing Kang Chuan Ji Pha

(1)

Nanjing Qingpu Biotechnol

(1)

Nanjing University of Chi

(1)

Nanjing University of Sci

(1)

Nanjing Vocational Colleg

(1)

Nanjing Weichuangyuan Pha

(1)

Nanjing Zenkom Pharmaceut

(1)

Nanjing Zhongyuansheng Bi

(1)

Nanocarry Therapeutics Lt

(1)

Nantong Huideseng Packagi

(1)

Nantong Infectious Diseas

(1)

Nantong Jiaxi Pharmaceuti

(1)

Nantong Mishuifang Sleep

(1)

Nantong Wannianchang Phar

(1)

Nanzhao County Xinglida A

(1)

Narodowy Inst Lekow [pl];

(1)

Natsar Pharmaceuticals In

(1)

Ncpc Hebei Huamin Pharmac

(1)

Neuheit Pharma Tech Pvt L

(1)

(1)

NewAmsterdam Pharma

(1)

Newave Pharmaceutical

(1)

Nianqingbao Pharmaceutica

(1)

Ningbo Accurant Detection

(1)

Ningbo Medical Treatment

(1)

Ningbo Ocean Pharmaceutic

(1)

Ningxia Medical Universit

(1)

Nippon Pharmaceutical Co

(1)

No 1 Affiliated Hospital

(1)

No 704 Research Institute

(1)

Nomi Biotech Corp Spolka

(1)

Nona Biosciences Suzhou

(1)

Northeast Electric Power

(1)

Northeastern University;

(1)

Northwestern University

(1)

(1)

(1)

Novartis Ag [ch]; Servier

(1)

Novartis; Servier Laborat

(1)

Novex Science Pte Ltd (n

(1)

Nucmito Pharmaceuticals C

(1)

Nurix Therapeutics Inc [u

(1)

ORIC Pharmaceuticals

(1)

Obi Pharma Inc [cn]; Chen

(1)

Ofd Biopharma Llc

(1)

Ohara Kk; Nagadka Univ Of

(1)

Olatec Therapeutics Inc

(1)

(1)

Oncternal Therapeutics In

(1)

Osaka Univ [jp]; Cuorips

(1)

Otsuka Pharmaceutical Dev

(1)

Ouhuameike Shanghai Medic

(1)

PTC Therapeutics

(1)

Pace Diagnostics Inc

(1)

Paean Biotechnology Inc [

(1)

Paradigm Biopharmaceutica

(1)

Paragon Therapeutics

(1)

Partner Therapeutics Inc

(1)

Passion Tech Zhuhai Partn

(1)

Patel Jayendrakumar Dasha

(1)

Pediatric Immunity And He

(1)

Peking University

(1)

Peking University School

(1)

Peking University Third H

(1)

Pengjun Guangzhou Biotech

(1)

People\'s Hospital of Tib

(1)

Perspective Therapeutics

(1)

Pharmaceutical Factory Of

(1)

Pharmacosmos Ltd

(1)

Pharmahungary 2000 Kft [h

(1)

(1)

Phenex Pharmaceuticals Ag

(1)

(1)

Pierre Fabre Dermo Cosmet

(1)

Pierre Fabre Medicament

(1)

Pilon Thomas Shari [us];

(1)

Plasticure Therapeutics I

(1)

Plaxis Prec Pharmaceutica

(1)

Ponce Medical School Foun

(1)

Poonglim Pharmatech Inc

(1)

Portal Therapeutics Inc

(1)

Poseida Therapeutics

(1)

Prana Therapies Inc

(1)

Precogify Pharmaceutical

(1)

Preglem Sa (preglem Sa)

(1)

Prestige Biologics Co Ltd

(1)

Procter & Gamble

(1)

Promotion Therapeutics In

(1)

Provectus Pharmatech Inc

(1)

Provincial Hospital Affil

(1)

Pu Pharmaceuticals

(1)

Purdue Pharma Lp (purdue

(1)

Pure Care Pro Llc

(1)

Qilu Animal Health Produc

(1)

Qilu Antibiotics Pharmace

(1)

Qilu Pharmaceutical Inner

(1)

Qilu University of Techno

(1)

Qilu University of Techno

(1)

Qingdao Guohai Biopharmac

(1)

Qingdao Huanghai Universi

(1)

Qingdao Municipal Hospita

(1)

Qingdao Ruiside Medical L

(1)

Qingdao University

(1)

Qingfeng Lianshi Biotechn

(1)

Qingzhi Biotechnology Xuz

(1)

Qiqihar Hospital Of Tradi

(1)

Ranok Therapeutics Hangzh

(1)

Redcarbonpharm Ltd

(1)

Redhill Biopharma Ltd

(1)

Relieve Therapeutics Pte

(1)

Rempex Pharmaceuticals In

(1)

Renji Hospital Shanghai J

(1)

Renji Hospital Shanghai J

(1)

Research & Business Found

(1)

Resolys Bio Inc

(1)

Rheinische Friedrich Wilh

(1)

(1)

(1)

Rigerna Therapeutics Beij

(1)

Rightleader Shanghai Tech

(1)

Rinri Therapeutics Ltd

(1)

Romano Jeannie [ph]; Roma

(1)

Rongchang Pharmaceutical

(1)

Ruddy Marcella [us]; Rege

(1)

Ruijin Hospital Shanghai

(1)

Ruijin Hospital Shanghai

(1)

Rusheng Shandong Pharmace

(1)

S In Te S Ia Srl

(1)

(1)

SINOTRUK Jinan Power; Sha

(1)

Sage Therapeutics Llc

(1)

Sage Therapeutics Llc [us

(1)

Sail Biomedicines

(1)

Saint Louis Univ [us]; US

(1)

Saiweitai Guangzhou Healt

(1)

Sanjin Group Hunan Sanjin

(1)

(1)

Sanofi Aventis; Eli Lilly

(1)

Sanyecao Hongkong Life Sc

(1)

Schedule 1 Therapeutics I

(1)

Scherer Technologies

(1)

Second Hospital Iaxing

(1)

Semnur Pharmaceuticals In

(1)

Seo Suk Bae [kr]; Kim Ja

(1)

Serta Therapeutics Ltd

(1)

Servier Laboratories

(1)

Shaanxi Bailu Pharmaceuti

(1)

Shaanxi Buchang Pharma Co

(1)

Shaanxi Huayuan Zhenghe P

(1)

Shaanxi Huifu Pharmaceuti

(1)

Shaanxi Mai Yuan Biotechn

(1)

Shaanxi Normal University

(1)

Shaanxi Tiandiren Traditi

(1)

Shaanxi Tianxitang Pharma

(1)

Shaanxi University of Tec

(1)

Shandong Academy of Pharm

(1)

Shandong Animal Disease P

(1)

Shandong Bestcomm Pharmac

(1)

Shandong Dingzhen Liquor

(1)

Shandong First Medical Un

(1)

Shandong Fupai Pharmaceut

(1)

Shandong Hongjitang Pharm

(1)

Shandong Institute of Med

(1)

Shandong Kangshengda New

(1)

Shandong Kexin Pharmaceut

(1)

Shandong Lurui Pharmaceut

(1)

Shandong Luye Pharmaceuti

(1)

Shandong Runjun Pharmaceu

(1)

Shandong Taihe Pharmaceut

(1)

Shandong Yidaokang Pharma

(1)

Shandong Yirentang Pharma

(1)

Shandong Yuecaotang Pharm

(1)

Shandong Zhaoguan Pharmac

(1)

Shangdong Luoxin Pharmace

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai Aerospace System

(1)

Shanghai Argo Biopharmace

(1)

Shanghai Artificial Intel

(1)

Shanghai Baoye Group Corp

(1)

Shanghai Beitong Enterpri

(1)

Shanghai Beitong Pharmace

(1)

Shanghai Boao Mingsai Bio

(1)

Shanghai Center For Clini

(1)

Shanghai Changzheng Hospi

(1)

Shanghai Data Group Co Lt

(1)

Shanghai Fangyu Health Ph

(1)

Shanghai Fenghua Tianlito

(1)

Shanghai Fudan Forward Ph

(1)

Shanghai Guang Sheng Phar

(1)

Shanghai Haihe Pharmaceut

(1)

Shanghai Heqing Dragon Fr

(1)

Shanghai Hospital Traditi

(1)

Shanghai Huidun Yintai Bi

(1)

Shanghai Huiji Pharmaceut

(1)

Shanghai Huilun Pharmaceu

(1)

Shanghai Inst Of Pharmace

(1)

Shanghai Institute of Mat

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Country

X

China Patent News

European Patent News

WIPO Patent News

Philippines Patent News

New Zealand Patent News

Poland Patent News

Peru Patent News

Sweden Patent News

Status

X

1 - 100 of 1767 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

U.S. Patent and Trademark Office Receives Curevac Netherlands BV Patent Application for Off-the-shelf Cancer Vaccines

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Curevac Netherlands BV patent application for Off-the-shelf Cancer Vaccines. Plasterk Ronald Hans Anton developed the invention. The patent application number is US202519265247 20250710. The patent publication number is US20260070955 (A1). International Pat..

4moving Biotech, Sorbonne University, Assist Publique Hopitaux De Paris APHP and Institut National De La Sante Et De La Rech Medicale Inserm Seek Patent for Composition and Methods..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- 4moving Biotech, Sorbonne University, Assist Publique Hopitaux De Paris APHP and Institut National De La Sante Et De La Rech Medicale Inserm have sought patent for Composition and Methods for Regulating Chondrocyte Proliferation and Increasing of Cartilage Matrix Production. This invention was developed b..

Paean Biotechnology Inc and Seoul National University R&DB Foundation Submit United States Patent Application for Pharmaceutical Composition, for Preventing or Treating Hearing Los..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Paean Biotechnology Inc and Seoul National University R&DB Foundation have submitted a patent application for Pharmaceutical Composition, for Preventing or Treating Hearing Loss or Tinnitus, Comprising Mitochondria as Active Ingredient. This invention was developed by Kang Young Cheol, Han Kyuboem, Kim Ch..

U.S. Patent and Trademark Office Releases Julius Maximilians University Wuerzburg In Vertretung Des Freistaates Bayern Patent Application for Receptacle, Device for Releasing Carbo..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released Julius Maximilians University Wuerzburg In Vertretung Des Freistaates Bayern patent application for Receptacle, Device for Releasing Carbon Monoxide, Treatment System, Set for Treating Living Cells, Method of Treating a Mammal, and Carbon Monoxide. This invent..

Aconcagua Bio Inc Files United States Patent Application for Compounds, Compositions, and Methods

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Aconcagua Bio Inc has filed a patent application for Compounds, Compositions, and Methods. This invention was developed by Gao Zhenting, Guo Xin, Lei Hui, Li Cui, Lu Chunliang, Xue Ding, Zhang Haizhen and Zhang Zhuming. The patent application number is US202519346244 20250930. The patent publication nu..

Arvinas Operation Inc Submits United States Patent Application for Vepdegestrant for Use in Treating Cancer

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Arvinas Operation Inc has submitted a patent application for Vepdegestrant for Use in Treating Cancer. This invention was developed by Peck Ronald, Taylor Lan Charles Anthony, Keung Chi Fung, Anderson Sibyl, Gough Sheryl Maxine and Flanagan John J. The patent application number is US202519107535 202502..

Dermavant Sciences GmbH Applies for Patent on Isoquinoline Compounds and Their Use in Treating Ahr Mediated Diseases

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Dermavant Sciences GmbH has applied United States patent for Isoquinoline Compounds and Their Use in Treating Ahr Mediated Diseases. Rubenstein David Scott and Mchale Kimberly Ann developed it. The patent application number is US202319107415 20230830. The patent publication number is US20260069585 (A1)..

Chongqing Kang Ju Quan Hong Biotechnology Co Ltd Submits Chinese Patent Application for Preparation Method of Fully Soluble Animal Plasma

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- Chongqing Kang Ju Quan Hong Biotechnology Co Ltd has submitted a patent application for Preparation Method of Fully Soluble Animal Plasma. This invention was developed by Fu Qiang, Chen Yufeng and Chen Xin. The patent application number is CN20251160050 20250730. The patent publication number is CN1208203..

Lu Pengcheng and Zunyi Medical University Apply for Patent on Self-adaptive Multi-source Heat Management Medicine Ultralow Temperature Cold Chain Intelligent Box System

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- Lu Pengcheng and Zunyi Medical University have applied Chinese patent for Self-adaptive Multi-source Heat Management Medicine Ultralow Temperature Cold Chain Intelligent Box System. Lu Pengcheng, Long Jinying, Wang Minghua, Zhao Lan, Chen Yuxuan, Li Kaiyuan, Chen Bingyu, Li Yu, Zhang Chun, Xi Zhangming, Shi ..

Tianjin University and Southern University of Science and Technology Submit Chinese Patent Application for Energy Storage Device and Reactor for Producing Hydrogen by Electrolyzing..

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- Tianjin University and Southern University of Science and Technology have submitted a patent application for Energy Storage Device and Reactor for Producing Hydrogen by Electrolyzing Water. This invention was developed by Sun Mingwei, Tian Zhenyu, Ma Fei, Chen Haopeng, Li Wenjia and Zhao Tianshou. The pat..

CETC Zhiwei Shanghai Technology and Shanghai Jiao Tong University Submit Chinese Patent Application for Predictive Maintenance and Energy-saving Linkage Method and Device for Indus..

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- CETC Zhiwei Shanghai Technology and Shanghai Jiao Tong University have submitted a patent application for Predictive Maintenance and Energy-saving Linkage Method and Device for Industrial Air Conditioner, Electronic Equipment and Computer Readable Storage Medium. This invention was developed by Hua Laizhen, ..

Shandong First Medical University & Shandong Academy Of Medical Sciences and Shandong Sky Grand Bio Pharmaceutical Co Ltd Submit Patent Application for Application of Reagent for Q..

Pharmaceutical

| Tue 17 Mar 2026

Alexandria, March 17 -- Shandong First Medical University & Shandong Academy Of Medical Sciences and Shandong Sky Grand Bio Pharmaceutical Co Ltd have submitted a patent application for Application of Reagent for Quantitative Detection of Pyroglutamyl Aminopeptidase in the Diagnosis of Rheumatoid Arthritis. Zhang Renshuai, Jiang..

Shanghai Jiao Tong University and China Power Complete Equipment Co Ltd File Chinese Patent Application for Composite Bifunctional Material for Capturing Carbon Dioxide and Synergi..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Shanghai Jiao Tong University and China Power Complete Equipment Co Ltd have filed a patent application for Composite Bifunctional Material for Capturing Carbon Dioxide and Synergistically Purifying Nitrogen Oxide as Well as Preparation Method and Application of Composite Bifunctional Material. This inventio..

Ruddy Marcella, Regeneron Pharmaceuticals Inc and Sanofi Biotechnology Submit United States Patent Application for Methods for Treating Bullous Pemphigoid by Administering an IL-4R..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Ruddy Marcella, Regeneron Pharmaceuticals Inc and Sanofi Biotechnology have submitted a patent application for Methods for Treating Bullous Pemphigoid by Administering an IL-4R Antagonist. This invention was developed by Deshpande Deepti R, Laws Elizabeth, Mannent Leda, Ruddy Marcella and Shabbir Arsalan ..

GlaxoSmithKline Intellectual Property Development Ltd and Fimbrion Therapeutics Inc Submit United States Patent Application for Substituted Biphenyl or Phenylheteroaryl-mannosides ..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- GlaxoSmithKline Intellectual Property Development Ltd and Fimbrion Therapeutics Inc have submitted a patent application for Substituted Biphenyl or Phenylheteroaryl-mannosides as Antagonists of FimH. This invention was developed by Bishop Michael Joseph, Janetka James Walter, Mcgrane Laurel Kathryn and Wi..

Cornell University and Sanders Tri Institute Therapeutics Discovery Institute Submit United States Patent Application for Tnks2 Inhibitors

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Cornell University and Sanders Tri Institute Therapeutics Discovery Institute have submitted a patent application for Tnks2 Inhibitors. This invention was developed by Dow Lukas, Zimmerman Jill, Huggins David J, Finkin-groner Efrat, Ginn John, Liverton Nigel, Liang Rui, Sun Shan, Khan Tanweer A and Fukase..

Shanghai University of Traditional Chinese Medicine and Shanghai Institute of Materia Medica, Chinese Academy of Sciences Apply for Patent on Application of Anthraquinone Compound ..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Shanghai University of Traditional Chinese Medicine and Shanghai Institute of Materia Medica, Chinese Academy of Sciences have applied Chinese patent for Application of Anthraquinone Compound and Medicinal Salt Thereof in Preparation of Medicine for Treating Anemia. Zhu Shiguo, Zhao Weimin, Zhou Yufu, Chang ..

Shanghai Yunsheng Yanxin Biological Tech Co Ltd and Bozhiyan New Taizhou Pharmaceutical Tech Co Ltd Seek Patent for Epinastine Hydrochloride Oral Soluble Film Composition as Well a..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Shanghai Yunsheng Yanxin Biological Tech Co Ltd and Bozhiyan New Taizhou Pharmaceutical Tech Co Ltd have sought patent for Epinastine Hydrochloride Oral Soluble Film Composition as Well as Preparation Method and Application Thereof. This invention was developed by Ying Shuhuan, Fu Jun, Lu Pengcheng, Guo Zhen..

Suzhou Wangshan Wangshui Biological Medicine Co Ltd and Wangshan Wangshui Lianyungang Pharmaceutical Co Ltd Submit Chinese Patent Application for Oral Soluble Film Preparation as W..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Suzhou Wangshan Wangshui Biological Medicine Co Ltd and Wangshan Wangshui Lianyungang Pharmaceutical Co Ltd have submitted a patent application for Oral Soluble Film Preparation as Well as Preparation Method and Application Thereof. This invention was developed by Yang Rulei, Wu Fengying, Ma Qing, Shi Songan..

KPC Pharmaceuticals Inc and Shanghai Kunheng Pharmaceutical Tech File Chinese Patent Application for Topiramate Sustained-release Pellet Coating Solution and Preparation Method The..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- KPC Pharmaceuticals Inc and Shanghai Kunheng Pharmaceutical Tech have filed a patent application for Topiramate Sustained-release Pellet Coating Solution and Preparation Method Thereof. This invention was developed by Wang Liping, Liu Ming, Jin Xuefeng, Ouyang Qunxiang, Long Wei and Liu Junfeng. The paten..

Genentech Inc and Roche Sequencing Solutions Seek Patent for Density-based Immunophenotyping

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Genentech Inc and Roche Sequencing Solutions have sought patent for Density-based Immunophenotyping. This invention was developed by Kolster Hauke, Kozlowski Cleopatra, Ruderman Daniel Lee and Leo Patrick Joseph. The patent application number is US202519391554 20251117. The patent publication number is..

Huida Shanghai Biotechnology Co Ltd and Pfizer Gene Therapeutics Singapore Pte Ltd Submit Patent Application for Guide Nucleic Acids Targeting Vegfa and Uses Thereof

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Huida Shanghai Biotechnology Co Ltd and Pfizer Gene Therapeutics Singapore Pte Ltd have submitted a patent application for Guide Nucleic Acids Targeting Vegfa and Uses Thereof. Wang Xing developed the invention. The patent application number is CN20248016434 20240412. The patent publication number is CN12..

Institut National De La Sante Et De La Rech Medicale, Centre National De La Recherche Scient, University Paris Cite and Assist Publique Hopitaux De Paris Seek Patent for Use of an ..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Institut National De La Sante Et De La Rech Medicale, Centre National De La Recherche Scient, University Paris Cite and Assist Publique Hopitaux De Paris have sought patent for Use of an Agent Capable of Inhibiting the Activation of Mait Cells for the Treatment of Rheumatoid Arthritis. This invention was ..

Provectus Pharmatech Inc and Urinary Tract Infections Seek Patent for Method of Treating Amyotrophic Lateral Sclerosis

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Provectus Pharmatech Inc and Urinary Tract Infections have sought patent for Method of Treating Amyotrophic Lateral Sclerosis. This invention was developed by Narendran Aru, Zhao Yusheng, Rodrigues Dominic, Pershing Edward V and Wachter Eric A. The patent application number is US202519323435 20250909. ..

Sanofi Aventis and Eli Lilly and Company Submit Chinese Patent Application for Anti-tumor Combination Comprising Anti-ceacam5 Antibody-drug Conjugate, Anti-VEGFR-2 Antibody and Ant..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Sanofi Aventis and Eli Lilly and Company have submitted a patent application for Anti-tumor Combination Comprising Anti-ceacam5 Antibody-drug Conjugate, Anti-VEGFR-2 Antibody and Anti-PD1/PD-l1 Antibody. This invention was developed by Khadja Mustafa and Denis Pascal. The patent application number is CN20..

U.S. Patent and Trademark Office Receives Sanofi-Aventis Deutschland Patent Application for Medicament Container Carrier and Adapter

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Sanofi-Aventis Deutschland patent application for Medicament Container Carrier and Adapter. Fenlon Derek, Launois Pascal, Mcdonnell Julian, Moyne Martina and Mulcahy Conor developed the invention. The patent application number is US202519388368 20251113. The ..

Sanofi-Aventis Deutschland Seeks Patent for Drive Operation Powering for Large-volume Delivery Device

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Sanofi-Aventis Deutschland has sought patent for Drive Operation Powering for Large-volume Delivery Device. This invention was developed by Anderson Marc and Ziniti Donald. The patent application number is US202418826925 20240906. The patent publication number is US20260069771 (A1). International Patent ..

Sanofi-Aventis Deutschland Applies for Patent on Drive Mechanism for Large Volume Delivery Device

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Sanofi-Aventis Deutschland has applied United States patent for Drive Mechanism for Large Volume Delivery Device. Anderson Marc and Ziniti Donald developed it. The patent application number is US202418826573 20240906. The patent publication number is US20260069770 (A1). International Patent Classificatio..

Kite Pharma Seeks Patent for Methods and Compositions for T Cell Therapy

Pharmaceutical

| Tue 17 Mar 2026

Alexandria, March 17 -- Kite Pharma has sought patent for Methods and Compositions for T Cell Therapy. This invention was developed by Bot Adrian I, Budka Justin, Chou Szu-ting, Milletti Francesca, Plaks Vicki and Rossi John M. The patent application number is US202519265167 20250710. The patent publication number is US20260072..

U.S. Patent and Trademark Office Releases Northwestern University Patent Application for Compositions and Methods for Screening and Identifying Immune Modulators

Pharmaceutical

| Tue 17 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released Northwestern University patent application for Compositions and Methods for Screening and Identifying Immune Modulators. This invention was developed by Zhang Xiaoyu, Zhang Chenlu and Zhou Chen. The patent application number is US202519083185 20250318. The ..

U.S. Patent and Trademark Office Releases Pace Diagnostics Inc Patent Application for Mycobacterium Tuberculosis Proteins in Diagnostic Assays and Devices for Tuberculosis Detectio..

Pharmaceutical

| Tue 17 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released Pace Diagnostics Inc patent application for Mycobacterium Tuberculosis Proteins in Diagnostic Assays and Devices for Tuberculosis Detection and Diagnosis. This invention was developed by Nguyen Hiep-hoa T. The patent application number is US202519074333 202..

Amgen Submits Patent Application for Methods of Detecting Off-target Binding of Proteins

Pharmaceutical

| Tue 17 Mar 2026

Alexandria, March 17 -- Amgen has submitted a patent application for Methods of Detecting Off-target Binding of Proteins. Yang Melissa, Mock Marissa, Hubert René Simon and Sun Wenchao developed the invention. The patent application number is US202519324289 20250910. The patent publication number is US20260072017 (A1). Internat..

U.S. Patent and Trademark Office Releases WELT Patent Application for Method and Apparatus for Controlling Pharmaceutical Mixer Based on User's Phenotype

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released WELT patent application for Method and Apparatus for Controlling Pharmaceutical Mixer Based on User's Phenotype. This invention was developed by Shim Hwa Jin, Kim Hye Ryong, Kang Seong Ji and Roh Hye Kang. The patent application number is US202519395293 20251..

Watt Emmalyne Laura Files United States Patent Application for Mental Health Therapeutic Treatment Method

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Watt Emmalyne Laura has filed a patent application for Mental Health Therapeutic Treatment Method. The patent application number is US202418826786 20240906. The patent publication number is US20260074051 (A1). International Patent Classification codes are G16H10/60, G16H20/70 and G16H80/00. Cooperativ..

U.S. Patent and Trademark Office Releases Genentech Inc and Hoffmann-La Roche Patent Application for Three-dimensional Molecule Generation by Denoising Voxel Grids

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released Genentech Inc and Hoffmann-La Roche patent application for Three-dimensional Molecule Generation by Denoising Voxel Grids. This invention was developed by Oliveira Pinheiro Pedro Henrique, Saremi Saeed, Maser Michael R and Nowara Ewa Magdalena. The patent a..

U.S. Patent and Trademark Office Publishes Genentech Inc and Hoffmann-La Roche Patent Application for Three-dimensional Molecule Generation in Latent Voxelized Space

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has published Genentech Inc and Hoffmann-La Roche patent application for Three-dimensional Molecule Generation in Latent Voxelized Space. The invention was developed by Maser Michael R, Nowara Ewa Madgalena, Oliveira Pinheiro Pedro Henrique and Saremi Saeed. The patent ..

Pfizer Submits Patent Application for Computerized Decision Tool for SARS-CoV-2 Variants Prediction

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Pfizer has submitted a patent application for Computerized Decision Tool for SARS-CoV-2 Variants Prediction. Anderson Annaliesa Sybil, Saha Subrata, Swanson Kena Anne and Yang Qi developed the invention. The patent application number is US202319105275 20230817. The patent publication number is US202600..

U.S. Patent and Trademark Office Releases Seo Suk Bae, Kim Ja Young and Seo Ho Joon Patent Application for Needle Unit for Injecting Drug and Skin Treatment Device Including the Sa..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released Seo Suk Bae, Kim Ja Young and Seo Ho Joon patent application for Needle Unit for Injecting Drug and Skin Treatment Device Including the Same. The patent application number is US202519333814 20250919. The patent publication number is US20260069795 (A1). Int..

U.S. Patent and Trademark Office Publishes Sanofi-Aventis Deutschland Patent Application for Method of Operating a Large-volume Delivery Device

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has published Sanofi-Aventis Deutschland patent application for Method of Operating a Large-volume Delivery Device. The invention was developed by Anderson Marc and Ziniti Donald. The patent application number is US202418826782 20240906. The patent publication number is U..

Sanofi-Aventis Deutschland Seeks Patent for Method of Assembling a Large Volume Delivery Device

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Sanofi-Aventis Deutschland has sought patent for Method of Assembling a Large Volume Delivery Device. This invention was developed by Anderson Marc and Ziniti Donald. The patent application number is US202418826562 20240906. The patent publication number is US20260069763 (A1). International Patent Classi..

State Intellectual Property Office of China Releases Jiangxi Juci Tech Co Ltd Patent Application for High-temperature Conductive Graphene Liquid Medicine and Preparation Method The..

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- State Intellectual Property Office of China has released Jiangxi Juci Tech Co Ltd patent application for High-temperature Conductive Graphene Liquid Medicine and Preparation Method Thereof. This invention was developed by Liu Jianxin. The patent application number is CN202510910691 20250702. The patent pu..

State Intellectual Property Office of China Releases Fan Meng Patent Application for Synergistic Effect Method of Traditional Chinese Medicine Dosage Gradient Scheme in Insomnia Tr..

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- State Intellectual Property Office of China has released Fan Meng patent application for Synergistic Effect Method of Traditional Chinese Medicine Dosage Gradient Scheme in Insomnia Treatment Based on Prescription Dosage-efficiency Theory. This invention was developed by Fan Meng. The patent application n..

Guangdong Xingbang Pharmaceutical Co Ltd Seeks Patent for Community Hospital Multi-source Prescription Intelligent Examination and Decoction Preparation Cooperation Method and Syst..

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- Guangdong Xingbang Pharmaceutical Co Ltd has sought patent for Community Hospital Multi-source Prescription Intelligent Examination and Decoction Preparation Cooperation Method and System. This invention was developed by Wu Xiuxue, Wu Yuzhan, Wu Gaoxiao, Yuan Wu and Zheng Mianzhi. The patent application n..

Shanghai Beitong Pharmaceutical Tech Consulting Co Ltd Submits Chinese Patent Application for Data Monitoring Method and Device for Medicine Collection Channel

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- Shanghai Beitong Pharmaceutical Tech Consulting Co Ltd has submitted a patent application for Data Monitoring Method and Device for Medicine Collection Channel. This invention was developed by Huang Xujiang. The patent application number is CN202510824955 20250619. The patent publication number is CN12082..

State Intellectual Property Office of China Releases Zhongjiang County People's Hospital Patent Application for Method for Generating Traditional Chinese Medicine Personalized Nurs..

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- State Intellectual Property Office of China has released Zhongjiang County People's Hospital patent application for Method for Generating Traditional Chinese Medicine Personalized Nursing Scheme for Preventive Treatment of Diseases. This invention was developed by Yang Juan, Tang Meimei and Shen Junru. The ..

Chongqing University Seeks Patent for Semi-template Drug Molecule Inverse Synthesis Prediction Method Based on Graph-sequence Pre-training

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- Chongqing University has sought patent for Semi-template Drug Molecule Inverse Synthesis Prediction Method Based on Graph-sequence Pre-training. This invention was developed by Hu Ji, Zhang Xiaohong, Cheng Cheng and Shi Xinyue. The patent application number is CN202510977886 20250716. The patent publication..

Inner Mongolia University for Nationalities Submits Patent Application for Traditional Chinese Medicine Preparation Quality Control Method and System Based on Big Data

Pharmaceutical

| Tue 17 Mar 2026

Beijing, March 17 -- Inner Mongolia University for Nationalities has submitted a patent application for Traditional Chinese Medicine Preparation Quality Control Method and System Based on Big Data. Zhang Dongwei, Jin Hua, Ta Na and Liu Yuehui developed the invention. The patent application number is CN202510957104 20250711. The..

ETA SA Manufacture Horlogère Suisse Submits United States Patent Application for Watchcase with Capsule

Pharmaceutical

| Tue 17 Mar 2026

Alexandria, March 17 -- ETA SA Manufacture Horlogère Suisse has submitted a patent application for Watchcase with Capsule. This invention was developed by Willemin Roger and Bringolf Martial. The patent application number is US202519286757 20250731. The patent publication number is US20260072411 (A1). International Patent Cl..

Phenomenex Inc Files United States Patent Application for Composition of Chromatographic Sorbents and Methods for Analysis of Antibody Drug Conjugates

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Phenomenex Inc has filed a patent application for Composition of Chromatographic Sorbents and Methods for Analysis of Antibody Drug Conjugates. This invention was developed by Mai Chengkang, Rustamov Ismail, Sanchez A Carl, Hoang Cuong Ngoc and Czaun Miklos. The patent application number is US202319107..

Bausch Lomb Ireland Submits United States Patent Application for Fractionated Drug Delivery of Biological or Chemical Agents

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Bausch Lomb Ireland has submitted a patent application for Fractionated Drug Delivery of Biological or Chemical Agents. This invention was developed by Blumenkranz Mark S, Ivri Yehuda, Quintana Reynaldo and Palanker Daniel V. The patent application number is US202519386603 20251112. The patent publicatio..

U.S. Patent and Trademark Office Receives Spyglass Pharma Inc and The Regents of the University of Colorado, a body corporate Patent Application for Stabilized Intraocular Drug Del..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Spyglass Pharma Inc and The Regents of the University of Colorado, a body corporate patent application for Stabilized Intraocular Drug Delivery Systems and Methods of Use. Cable Ii Craig Alan, Kahook Malik Y, Sussman Glenn R and Maass Sean developed the invent..

U.S. Patent and Trademark Office Releases 3i Biotech LLC and Texas Tech University System Patent Application for Systems and Devices for the Delivery of Tailorable Medicament to th..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released 3i Biotech LLC and Texas Tech University System patent application for Systems and Devices for the Delivery of Tailorable Medicament to the Gingival Crevice and Methods Thereof. This invention was developed by Syn David, Ingrole Rohan, Boese Seth, Gill Harvind..

Immunotek Co Ltd Seeks Patent for Anti-cd2 Single Domain Antibodies, Pharmaceutical Compositions and Kits for Use in Diagnosis and/or Therapy of Cancer

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Immunotek Co Ltd has sought patent for Anti-cd2 Single Domain Antibodies, Pharmaceutical Compositions and Kits for Use in Diagnosis and/or Therapy of Cancer. This invention was developed by Crackhart Ashley M, Weber William A, Laselli Luigi, Da Lessandria Claudio and Gossmann Dietrich. The patent applicat..

Ascendis Pharma Seeks Patent for Pharmaceutical Compounds Comprising Albumin Binding Moieties

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Ascendis Pharma has sought patent for Pharmaceutical Compounds Comprising Albumin Binding Moieties. This invention was developed by Sprogu Karl, Bisek Nicola and Wisbrod Stefan. The patent application number is CN20248017316 20240305. The patent publication number is CN120826239 (A). International Patent Cl..

Mink Therapeutics Inc Submits Chinese Patent Application for Constant Natural Killer T Cells for Treating Acute Respiratory Distress Syndrome (ARDS)

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Mink Therapeutics Inc has submitted a patent application for Constant Natural Killer T Cells for Treating Acute Respiratory Distress Syndrome (ARDS). This invention was developed by Purbhu Manish. The patent application number is CN20238090195 20231106. The patent publication number is CN120826232 (A). In..

NOF Corp Submits Patent Application for Eye Drops

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- NOF Corp has submitted a patent application for Eye Drops. Sumi Azusa, Sasaki Yumiko and Hara Masao developed the invention. The patent application number is CN20248017091 20240314. The patent publication number is CN120826231 (A). International Patent Classification codes are A61K31/785, A61K47/59, A61K4..

Anovis Biologics Inc Submits Chinese Patent Application for Treatment of Mental Disorders by Administration of Buntanetap and Analogs Thereof

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Anovis Biologics Inc has submitted a patent application for Treatment of Mental Disorders by Administration of Buntanetap and Analogs Thereof. This invention was developed by Maccecchini Marco. The patent application number is CN20248015876 20240123. The patent publication number is CN120826227 (A). Inter..

State Intellectual Property Office of China Releases Algen Pharmaceuticals Inc Patent Application for Syllyinositol in Combination with Immunotherapeutic Agent for Treatment of Alz..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- State Intellectual Property Office of China has released Algen Pharmaceuticals Inc patent application for Syllyinositol in Combination with Immunotherapeutic Agent for Treatment of Alzheimer's Disease. This invention was developed by Frost Patrick, Kruse Alexander and Choi Jae Kyu. The patent application ..

Algen Pharmaceuticals Inc Submits Chinese Patent Application for Combination of Scyllo-inositol and Flavone

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Algen Pharmaceuticals Inc has submitted a patent application for Combination of Scyllo-inositol and Flavone. This invention was developed by Frost Patrick, Kruse Alexander, Choi Jae Kyu and Hsiao Jane H. The patent application number is CN20238075657 20230901. The patent publication number is CN120826222 ..

Algen Pharmaceuticals Inc Files Chinese Patent Application for Combination Therapy of Scyllinositol and Vitamin D And/or Other Vitamins or Active Ingredients to Treat Cognitive Dis..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Algen Pharmaceuticals Inc has filed a patent application for Combination Therapy of Scyllinositol and Vitamin D And/or Other Vitamins or Active Ingredients to Treat Cognitive Disorders. This invention was developed by Frost Patrick, Kruse Alexander, Choi Jae Kyu and Hsiao Jane H. The patent application nu..

U.S. Patent and Trademark Office Releases CVS Pharmacy Patent Application for Systems and Methods for Federated Knowledge Goverance

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has released CVS Pharmacy patent application for Systems and Methods for Federated Knowledge Goverance. This invention was developed by Danilchenko Victor A. The patent application number is US202418827114 20240906. The patent publication number is US20260073244 (A1). Int..

Ganacyte Therapeutics Inc Applies for Patent on Formulations of Pan-jak Inhibitors

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Ganacyte Therapeutics Inc has applied Chinese patent for Formulations of Pan-jak Inhibitors. Morgan Frazer Giles, Grinan Rebecca Annabelle Louise, Oliver Martin James and O 'brien Christopher D developed it. The patent application number is CN20238091953 20231201. The patent publication number is CN120826..

Chongqing Hongsheng Pharmaceutical Chemical Co Ltd Submits Patent Application for Filtering Device and Method for Pharmaceutical and Chemical Refining

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Chongqing Hongsheng Pharmaceutical Chemical Co Ltd has submitted a patent application for Filtering Device and Method for Pharmaceutical and Chemical Refining. Zhang Qiao, Xie Chongde, Ji Pengchao, Tan Xiaobing, Kuang Yuebo and Zhou Rongfeng developed the invention. The patent application number is CN2025..

U.S. Patent and Trademark Office Receives Chengdu Starray Therapeutics Co Ltd Patent Application for Ligand Compound Targeting PSMA Antigen, and Chelate and Use Thereof in Diagnosi..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Chengdu Starray Therapeutics Co Ltd patent application for Ligand Compound Targeting PSMA Antigen, and Chelate and Use Thereof in Diagnosis and Treatment of Prostate Cancer. Zhong Zhiyuan, Yuan Jiandong, Yang Jiangtao, Huangfu Zhenyuan, Sun Juan, Xu Bin and Ta..

U.S. Patent and Trademark Office Publishes Aratana Therapeutics Inc Patent Application for Eye Drop Composition

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has published Aratana Therapeutics Inc patent application for Eye Drop Composition. The invention was developed by Goris Nesva, Neyts Johan, Blomsma Erwin, Wera Stefaan, Billiet Ainola, Auwerx Joeri, Debeurme Veerle, Roe Maryline and Puig Pascal. The patent application ..

Shape Therapeutics Seeks Patent for Engineered Guide Rnas and Polynucleotides

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Shape Therapeutics has sought patent for Engineered Guide Rnas and Polynucleotides. This invention was developed by Savva Yiannis, Bagepalli Lina Rajili, Booth Brian, Briggs Adrian Wrangham, Sullivan Richard Thomas and Jiang Yue. The patent application number is US202519243831 20250620. The patent public..

Poseida Therapeutics Submits United States Patent Application for Lipidoid Compounds and Related Compositions and Uses

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Poseida Therapeutics has submitted a patent application for Lipidoid Compounds and Related Compositions and Uses. This invention was developed by Huang Lijun, Li Ling, Vemuri Gopi Nath and Hajj Khalid A. The patent application number is US202519272804 20250717. The patent publication number is US20260069..

Beijing Inno Medicine Co Ltd Submits United States Patent Application for Liposomal Nanocarrier Delivery System for Targeting Active CD44 Molecule, Preparation Method Therefor, and..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Beijing Inno Medicine Co Ltd has submitted a patent application for Liposomal Nanocarrier Delivery System for Targeting Active CD44 Molecule, Preparation Method Therefor, and Uses Thereof. This invention was developed by Ma Qian and Sun Jiefang. The patent application number is US202519388923 20251113...

Ascendis Pharma Seeks Patent for Drug Compounds Comprising Albumin-binding Moieties

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Ascendis Pharma has sought patent for Drug Compounds Comprising Albumin-binding Moieties. This invention was developed by Sprogøe Kennett, Bisek Nicola and Weisbrod Samuel. The patent application number is US202519257318 20250701. The patent publication number is US20260069702 (A1). International Patent..

U.S. Patent and Trademark Office Receives Augusta University Research Institute Inc and The US Government As Represented By The Dept Of Veterans Affairs Patent Application for Hybr..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Augusta University Research Institute Inc and The US Government As Represented By The Dept Of Veterans Affairs patent application for Hybrid Curcumin Conjugates and Methods of Use Thereof. Panda Siva S, Thangaraju Muthusamy and Lokeshwar Balakrishna L develope..

Shanghai Guang Sheng Pharmaceutical Co Ltd Submits United States Patent Application for Combined Therapy of Photodynamic Therapy and Immune Checkpoint Inhibitor

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Shanghai Guang Sheng Pharmaceutical Co Ltd has submitted a patent application for Combined Therapy of Photodynamic Therapy and Immune Checkpoint Inhibitor. This invention was developed by Zhang Shaoliang and Zhang Hao. The patent application number is US202519392078 20251117. The patent publication num..

Sovereign Middleman And Riley LLC Submits United States Patent Application for Compositions and Methods for Treating Autoimmune Diseases with Anti-CLL-1 Directed Therapy

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Sovereign Middleman And Riley LLC has submitted a patent application for Compositions and Methods for Treating Autoimmune Diseases with Anti-CLL-1 Directed Therapy. This invention was developed by Mandel Matt. The patent application number is US202519324059 20250909. The patent publication number is US..

Pilon Thomas Shari, Sarnaik Amod, H Lee Moffitt Cancer Center And Res Institute Inc and University of South Florida Submit United States Patent Application for Novel CD4+ Tumor Inf..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Pilon Thomas Shari, Sarnaik Amod, H Lee Moffitt Cancer Center And Res Institute Inc and University of South Florida has submitted a patent application for Novel CD4+ Tumor Infiltrating Lymphocytes for the Treatment of Cancer. The patent application number is US202319106715 20230828. The patent publicati..

U.S. Patent and Trademark Office Receives Merck Patent Patent Application for Treatment Regimen for the Treatment of Autoimmune Disorders

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Merck Patent patent application for Treatment Regimen for the Treatment of Autoimmune Disorders. Boschert Ursula and Wiedemann Urs developed the invention. The patent application number is US202519384362 20251110. The patent publication number is US2026006968..

CSL Behring Submits Patent Application for Haptoglobulin for Use in Treating or Preventing Exaggerated Erectile Response or Erectile Dysfunction

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- CSL Behring has submitted a patent application for Haptoglobulin for Use in Treating or Preventing Exaggerated Erectile Response or Erectile Dysfunction. Da Silva Fábio Henrique and Ferreira Costa Fernando developed the invention. The patent application number is US202319107058 20230901. The patent pu..

Resolys Bio Inc Submits Patent Application for Method of Treating Neuroinflammatory Symptoms of Central Nervous System (cns) Disorders by Administration of Cholesterol Dependent Cy..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Resolys Bio Inc has submitted a patent application for Method of Treating Neuroinflammatory Symptoms of Central Nervous System (cns) Disorders by Administration of Cholesterol Dependent Cytolysins (cdc). Sanders Mitchell and Mcmichael John developed the invention. The patent application number is US202..

Apellis Pharmaceuticals Applies for Patent on Complement Inhibitor Dosing Regimens

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Apellis Pharmaceuticals has applied United States patent for Complement Inhibitor Dosing Regimens. Francois Cedric, Deschatelets Pascal and Grossi Federico developed it. The patent application number is US202218707159 20221103. The patent publication number is US20260069653 (A1). International Patent Cla..

Haikou Qiaoshui United Tech Co Ltd Submits United States Patent Application for Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Haikou Qiaoshui United Tech Co Ltd has submitted a patent application for Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis. This invention was developed by Wang Jiaxi, Cao Jinna, Peng Rubin, Zhou Ji, Zhang Hongbin and Li Huicheng. The patent application number is US2025..

Bio Merieux Inc Submits Patent Application for Method for Determining Sensitivity of Mycobacterium Tuberculosis Strains to Pyrazinamide

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Bio Merieux Inc has submitted a patent application for Method for Determining Sensitivity of Mycobacterium Tuberculosis Strains to Pyrazinamide. Mahe Pierre, Tournoud Maud, Barras Philippe and Dancet M Gerard developed the invention. The patent application number is CN20248017496 20240307. The patent publ..

Rinri Therapeutics Ltd Submits United States Patent Application for Method for the Treatment of an Auditory Disease or Condition

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Rinri Therapeutics Ltd has submitted a patent application for Method for the Treatment of an Auditory Disease or Condition. This invention was developed by Li Hao, Rask-andersen Helge Eduard, Jiang Dan, O'donoghue Gerard Mary, Hartley Douglas Edward Hugh and Rivolta Carlos Marcelo Nicolas. The patent a..

Paradigm Biopharmaceuticals Ltd Applies for Patent on Treatment of Psoriasis, Psoriatic Arthritis and Dermatitis

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Paradigm Biopharmaceuticals Ltd has applied United States patent for Treatment of Psoriasis, Psoriatic Arthritis and Dermatitis. Rennie Paul, Krishnan Ravi and Bloom Philip developed it. The patent application number is US202319108856 20230906. The patent publication number is US20260069628 (A1). Inter..

The University of Hong Kong Files United States Patent Application for Cordycepin, Derivatives, Compositions and Methods Thereof

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- The University of Hong Kong has filed a patent application for Cordycepin, Derivatives, Compositions and Methods Thereof. This invention was developed by Shen Jiangang and Du Qiaohui. The patent application number is US202519322770 20250909. The patent publication number is US20260069623 (A1). Internat..

U.S. Patent and Trademark Office Receives Duke University Patent Application for Novel Equilibrative Nucleoside Transporter Inhibitors and Methods of Making and Using Same

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Duke University patent application for Novel Equilibrative Nucleoside Transporter Inhibitors and Methods of Making and Using Same. Lee Seok-yong, Hong Jiyong, Ji Ru-rong and Wright Nicholas developed the invention. The patent application number is US2023188..

U.S. Patent and Trademark Office Receives Madrigal Pharmaceuticals Patent Application for Resmetirom for Reducing Liver Volume

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- U.S. Patent and Trademark Office has received Madrigal Pharmaceuticals patent application for Resmetirom for Reducing Liver Volume. Taub Rebecca developed the invention. The patent application number is US202519386839 20251112. The patent publication number is US20260069598 (A1). International Patent Cla..

Weishang Shanghai Bio Pharmaceutical Co Ltd Submits United States Patent Application for Use of a Quinazoline Compound in Overcoming Osimertinib Resistance

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Weishang Shanghai Bio Pharmaceutical Co Ltd has submitted a patent application for Use of a Quinazoline Compound in Overcoming Osimertinib Resistance. This invention was developed by Zhong Wei. The patent application number is US202419107512 20240205. The patent publication number is US20260069592 (A1)..

Corcept Therapeutics Submits United States Patent Application for Methods for Reducing Weight and Preserving or Increasing Tissue Lean Mass in Patients Suffering from Cushing's Syn..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Corcept Therapeutics has submitted a patent application for Methods for Reducing Weight and Preserving or Increasing Tissue Lean Mass in Patients Suffering from Cushing's Syndrome. This invention was developed by Moraitis Andreas. The patent application number is US202519323835 20250909. The patent publi..

Sun Yat-sen University Files Chinese Patent Application for Extraction Device for Quality Analysis of Traditional Chinese Medicinal Materials and Extraction Method Thereof

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Sun Yat-sen University has filed a patent application for Extraction Device for Quality Analysis of Traditional Chinese Medicinal Materials and Extraction Method Thereof. This invention was developed by Gong Meihui and Miao Shengjie. The patent application number is CN20251124769 20250723. The patent public..

Schedule 1 Therapeutics Inc Submits United States Patent Application for Compositions Comprising Cannabinoids and Methods of Use

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Schedule 1 Therapeutics Inc has submitted a patent application for Compositions Comprising Cannabinoids and Methods of Use. This invention was developed by Pappas George D. The patent application number is US202519339926 20250925. The patent publication number is US20260069616 (A1). International Paten..

LEO Pharma Seeks Patent for Formulation of Delgocitinib in the Form of a Cream

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- LEO Pharma has sought patent for Formulation of Delgocitinib in the Form of a Cream. This invention was developed by Nielsen Jakob, Pedersen Gitte Pommergaard, Mortensen Helene, Sander Camilla and Refer Pia Klie. The patent application number is US202519385693 20251111. The patent publication number is U..

Sun Pharma Advanced Res Company Ltd Applies for Patent on Methods of Treating Chronic Myeloid Leukemia Using the Tyrosine Kinase Inhibitor Vodobatinib

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Sun Pharma Advanced Res Company Ltd has applied United States patent for Methods of Treating Chronic Myeloid Leukemia Using the Tyrosine Kinase Inhibitor Vodobatinib. Chimote Geetanjali Chandrasekhar, Talluri Ravi Sankar Prasad and Ramanathan Vikram developed it. The patent application number is US2023..

Relieve Therapeutics Pte Ltd Seeks Patent for Compositions and Methods for Pain Relief and Numbing

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Relieve Therapeutics Pte Ltd has sought patent for Compositions and Methods for Pain Relief and Numbing. This invention was developed by Waugh Jacob. The patent application number is US202519387836 20251113. The patent publication number is US20260069579 (A1). International Patent Classification codes ..

Union Therapeutics AS Submits United States Patent Application for Treatment of Neutrophilic Dermatoses

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Union Therapeutics AS has submitted a patent application for Treatment of Neutrophilic Dermatoses. This invention was developed by Taudorf Elisabeth Hjardem, Jemec Gregor B E and Kjøller Kim. The patent application number is US202318857955 20230418. The patent publication number is US20260069578 (A1)...

Vicore Pharma Applies for Patent on Treatment of Idiopathic Pulmonary Fibrosis

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Vicore Pharma has applied United States patent for Treatment of Idiopathic Pulmonary Fibrosis. Dalsgaard Carl-johan and Batta Rohit developed it. The patent application number is US202519389587 20251114. The patent publication number is US20260069572 (A1). International Patent Classification codes are A6..

State Intellectual Property Office of China Publishes Jecho Biopharma Inc Patent Application for Anti-mesothelin Bispecific Antibodies and Methods of Use Thereof

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- State Intellectual Property Office of China has published Jecho Biopharma Inc patent application for Anti-mesothelin Bispecific Antibodies and Methods of Use Thereof. The invention was developed by Zhu Jianwei, Wang Shusheng, Song Zhangyi, Huang Haiqiu, Yang Kaiyong, Xiao Xiaodong, Xie Yueqing and Jiang Hua...

Slayback Pharma Files United States Patent Application for Stable Pharmaceutical Compositions of Edaravone

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Slayback Pharma has filed a patent application for Stable Pharmaceutical Compositions of Edaravone. This invention was developed by Dube Sushant Omprakash, Kore Girish G, Pawar Abhijit Balaji, Lohar Jagdish Lotan, Subbappa Praveen Kumar, Pillai Sumitra Ashokkumar, Yenda Parvateesam and Balasubramanian Sat..

Emory University Submits Chinese Patent Application for Heterodimeric Antibodies, Uses in Therapeutic Applications and Compositions Related Thereto

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Emory University has submitted a patent application for Heterodimeric Antibodies, Uses in Therapeutic Applications and Compositions Related Thereto. This invention was developed by Sandberg Erik, To Jonathan and Azam Tara. The patent application number is CN20248017221 20240419. The patent publication numbe..

Sound Pharmaceuticals Inc Files United States Patent Application for Ebselen Containing Oral Dosage Forms

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Sound Pharmaceuticals Inc has filed a patent application for Ebselen Containing Oral Dosage Forms. This invention was developed by Kil Jonathan and Wall G Michael. The patent application number is US202318872701 20230606. The patent publication number is US20260069569 (A1). International Patent Classif..

State Intellectual Property Office of China Releases Taichengsi Biomedical Private Co Ltd Patent Application for Antibody Drug Conjugates Comprising Trabectedin and Rubitedin Deriv..

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- State Intellectual Property Office of China has released Taichengsi Biomedical Private Co Ltd patent application for Antibody Drug Conjugates Comprising Trabectedin and Rubitedin Derivatives. This invention was developed by Zou Bin and Yang Brian K S. The patent application number is CN20238095535 2023102..

Intrabio Ltd Submits United States Patent Application for Therapeutic Agents for Improved Mobility and Cognitive Function and for Treating Neurodegenerative Diseases and Lysosomal ..

Pharmaceutical

| Mon 16 Mar 2026

Alexandria, March 17 -- Intrabio Ltd has submitted a patent application for Therapeutic Agents for Improved Mobility and Cognitive Function and for Treating Neurodegenerative Diseases and Lysosomal Storage Disorders. This invention was developed by Factor Mallory. The patent application number is US202519356133 20251012. The ..

Impact Therapeutics Inc Seeks Patent for Substituted Nitrogen-containing Tricyclic Compound as Parp Inhibitor and Application Thereof

Pharmaceutical

| Mon 16 Mar 2026

Beijing, March 17 -- Impact Therapeutics Inc has sought patent for Substituted Nitrogen-containing Tricyclic Compound as Parp Inhibitor and Application Thereof. This invention was developed by Cai Sui Xiong, Tian Ye and Wang Xiaozhu. The patent application number is CN20248015860 20240229. The patent publication number is CN1..

1 to 100 of 1767 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles